How Are Prions Transmitted? Pathways and Prevention

Explore how unique protein structures propagate throughout systems and the essential measures safeguarding against their spread.

Prions spread through a surprisingly wide range of routes, from contaminated food and surgical instruments to soil, bodily fluids, and even the air under experimental conditions. Unlike bacteria or viruses, a prion is simply a misfolded version of a normal brain protein that forces neighboring proteins to adopt the same shape, triggering a chain reaction of damage in the nervous system. Because prions carry no DNA or RNA, they resist sterilization methods that would destroy conventional pathogens, making every transmission pathway harder to shut down than you might expect.

What a Prion Actually Does

Your body naturally produces a protein called PrP on the surface of nerve cells. In prion disease, that protein refolds from its normal shape into a compact, sticky form. The misfolded version acts as a template, converting nearby normal proteins into copies of itself. This sets off a self-amplifying cycle that eventually packs the brain with insoluble protein clumps, killing neurons and leaving the characteristic sponge-like holes visible under a microscope. The exact molecular trigger that tips the first protein from its healthy shape into the disease-causing one remains an open question, though researchers have identified intermediate folding states that appear to drive the process.

This self-replicating behavior is what makes prions transmissible in the first place. A tiny amount of misfolded protein entering the body can seed conversion of normal protein at the destination, eventually reaching the brain regardless of where it first gained entry. The routes that bring that initial seed into contact with the body are more varied than most people realize.

Eating Contaminated Tissue

The most widely known prion transmission pathway is dietary. The epidemic of variant Creutzfeldt-Jakob disease (vCJD) in the United Kingdom traced back to people eating beef products contaminated with the agent of bovine spongiform encephalopathy, commonly called mad cow disease. An older example is kuru, a prion disease that spread through ritualistic cannibalism in Papua New Guinea. In both cases, prions entered the body through the gut.

Once swallowed, prions have to cross the intestinal lining to reach lymphoid tissue and eventually the nervous system. Research in mice shows that specialized cells in the gut lining transport prions into immune structures called Peyer’s patches, where the misfolded protein accumulates on immune cells before spreading toward the brain. There is some debate about which gut cells do the initial heavy lifting. One in-vivo study found that ordinary intestinal lining cells with enlarged internal compartments, rather than the M cells often credited, appeared to take up most of the prion protein after oral exposure. Either way, the gut is clearly an efficient entry point.

Surgical Instruments and Medical Procedures

Iatrogenic transmission, meaning spread through medical procedures, is arguably the most troubling pathway because it can happen inside a hospital. Historically, cases have been linked to contaminated neurosurgical instruments, transplanted corneas, and injections of cadaver-derived human growth hormone. A recently reported case in the United States involved a patient who developed Creutzfeldt-Jakob disease after a latency period of over 48 years following treatment with cadaveric growth hormone. That extraordinary delay illustrates just how slowly prions can incubate before symptoms appear.

The reason surgical instruments pose a risk is that prions cling tenaciously to stainless steel and resist standard sterilization. Lab experiments found that steel wires exposed to prion-infected brain tissue retained massive amounts of infectivity even after extensive washing, and treatment with formaldehyde reduced the load only modestly. Longer drying times make things worse, because dried-on prion protein bonds more tightly to metal surfaces and becomes harder to remove with cleaning agents. Keeping instruments moist after use significantly reduces prion attachment and improves the effectiveness of subsequent decontamination.

Blood Transfusion

For decades, blood-borne prion transmission was considered theoretical. That changed in the early 2000s, when a patient in the United Kingdom developed vCJD after receiving red blood cells from a donor who later turned out to have the disease. The donor had given blood roughly three and a half years before developing symptoms, meaning the blood supply was contaminated during a silent incubation period. In total, five patients are suspected to have acquired vCJD or a vCJD infection through blood or plasma-derived products. All received non-leukodepleted blood products in the UK between 1994 and 1999, before universal removal of white blood cells from donated blood was adopted. The fact that all transfusion-linked cases predated leukodepletion supports the idea that vCJD prions ride along preferentially with white blood cells. Many countries now also ban blood donations from people who spent significant time in the UK during the BSE epidemic.

Chronic Wasting Disease and Wildlife

Chronic wasting disease (CWD) in deer, elk, and moose is arguably the prion disease that worries wildlife managers most, because it spreads horizontally between animals with remarkable efficiency. Infected deer shed prions in saliva, urine, and feces, and shedding begins long before any symptoms show up. One longitudinal study detected prion shedding in deer saliva and urine as early as three months after exposure, with sustained output throughout the disease. The researchers estimated that a single milliliter of infected saliva contained enough prions to be lethal in a mouse model, and that over the full course of infection, one deer could release thousands of infectious doses into the environment.

Fecal shedding appears to be the most consistent route. When elk, mule deer, and white-tailed deer were tested at intervals after oral inoculation, fecal samples were positive in roughly nine out of ten cases across all three species, while urine samples were positive about a quarter of the time. All three species were excreting prions by six months post-inoculation, well before any clinical signs appeared. This means an apparently healthy deer sharing a salt lick or water source with others can silently contaminate the landscape. The salivary gland, urinary bladder, and distal intestinal tract all showed high levels of prion-generating activity in infected deer, confirming that excretory tissues are major reservoirs.

Vertical Transmission From Mother to Offspring

In both livestock and wildlife, prions can pass from a mother to her offspring during pregnancy. In sheep and goats with classical scrapie, the placenta is a well-established source of horizontal transmission: other animals can become infected simply by encountering shed placental tissue in a shared lambing area. Research confirmed that feeding pooled placental tissue from a scrapie-infected goat to naïve goat kids and lambs produced disease in all four goats and two of four sheep tested. Prion protein and infectivity have been detected in the placenta of roughly 80% of scrapie-infected sheep.

For CWD, the picture is becoming clearer. A study of free-ranging white-tailed deer found infectious CWD prions in uterine tissue, the placenta, and even fetal brain and thymus. All mice inoculated with uterine or placental tissue developed disease, and over half of those inoculated with fetal brain tissue did as well. Earlier work in Reeves’ muntjac deer demonstrated CWD transmission to both in-utero fetuses and full-term offspring born to infected mothers, with prion seeding detectable in multiple tissues of every fetus and nonviable newborn tested. Vertical transmission may help explain why CWD spreads so stubbornly in wild deer populations even when direct animal-to-animal contact is limited.

Prions in Soil and on Plants

One of the most unsettling features of prion diseases is the way the environment itself becomes a reservoir. Prions shed in feces, urine, saliva, or decomposing carcasses bind tightly to clay minerals and other soil components. Experiments show that certain clay types can bind and remove over 99% of prion infectivity from a solution, effectively locking infectious material into the ground. Counterintuitively, prions bound to soil minerals remain infectious and can actually produce disease faster than unbound prions when introduced into an animal. In hamster experiments, animals inoculated with clay-bound prions developed scrapie symptoms far sooner than those receiving an equivalent dose of free-floating prions processed the same way.

Plants add another layer to the problem. Wheat grass roots and leaves readily bind prion protein from diluted brain tissue and from excretory materials like urine and feces. Prions sprayed onto living leaves remained detectable for weeks, and plants growing in contaminated soil took up prions through their roots and transported them to stems and leaves above ground. A broader follow-up confirmed that multiple crop and wild plant species can do this, not just grass. For grazing animals like deer, this means every mouthful of vegetation in a contaminated area could carry a low dose of prions. It also raises questions about whether agricultural land fertilized with biosolids could accumulate prions, since simulations of wastewater treatment found that prion protein partitions strongly to sewage sludge solids and survives the anaerobic digestion step used in most treatment plants.

Aerosol Exposure

Airborne transmission of prions sounds like science fiction, but laboratory experiments have demonstrated it under controlled conditions. Mice exposed to aerosols generated from prion-infected brain tissue developed scrapie with 100% attack rates at concentrations as low as 2.5%, and the disease appeared in both normal and immune-deficient mice. These results raised the concern that aerosols could be a real but underappreciated vehicle for prion spread in certain settings, such as slaughterhouses, rendering plants, or laboratory environments where infected tissue is handled. Whether aerosol exposure matters in natural field conditions for wildlife or livestock remains uncertain, but the lab data are striking enough to warrant protective measures for workers in high-risk facilities.

Spontaneous and Genetic Cases

Not all prion disease comes from external exposure. Most cases of Creutzfeldt-Jakob disease in humans are classified as sporadic, meaning the misfolding event appears to happen spontaneously with no identifiable source of infection. On top of that, about 10 to 15% of CJD patients carry mutations in the gene encoding the prion protein itself, making them genetically predisposed to misfolding. Many of these patients have a family history consistent with inherited disease, though some are identified only when genetic testing reveals unexpected mutations in people who initially looked like sporadic cases. The practical significance is that you can develop prion disease without ever encountering an external prion. It also means that genetic testing has a role in families with a history of unexplained neurological decline.

The Species Barrier and Why It Sometimes Fails

Prion transmission between species is generally much less efficient than transmission within a species. The misfolded protein from one animal does not always fit as a template for the normal prion protein of a different animal, because differences in the protein’s amino acid sequence change the shapes it can adopt. This mismatch is called the species barrier, and it is the main reason CWD in deer has not, so far, been confirmed to cause disease in humans. Research using yeast prion models has shown that the critical factor is not just how different the two proteins are in sequence, but whether a particular misfolded shape, or strain, happens to be compatible with the other species’ protein. Even small sequence changes in specific stretches of the prion domain can dramatically alter whether cross-species conversion succeeds or fails.

The worrying caveat is that prion strains can adapt. When a prion crosses into a new host species, serial passage through that host can gradually shift the misfolded protein’s properties until a new strain emerges that replicates efficiently in the new host. This process has been documented with transmissible mink encephalopathy, where interspecies transmission of a single prion strain led to the selection of at least two different misfolded conformations, with one eventually becoming dominant. Similar adaptation has been observed with synthetic prions passaged within the same host. The species barrier is real, but it is not a wall. Under the right circumstances, prions evolve their way around it.

Silent Carriers and Why That Matters

One of the harder problems in prion disease prevention is that infection can exist without symptoms for years or even decades. Large-scale surveys of human appendix tissue in Britain found abnormal prion protein at an estimated prevalence of roughly 1 in 2,000 people in the population exposed to BSE. A follow-up survey that included samples from both before and after the BSE exposure era found positive appendix samples in both groups, though the numbers were small. Strikingly, the genetic profile of the positive specimens did not match that of confirmed clinical vCJD cases: clinical patients were all one genetic type at a key position on the prion gene, while many of the silent positives were a different type. Whether these silent carriers will ever develop clinical disease, or whether they pose a risk through surgery or blood donation, remains unknown. This uncertainty is the main reason that stringent blood donor restrictions and surgical instrument protocols remain in place even though clinical vCJD cases have dwindled.

Decontamination and What Actually Works

Standard hospital sterilization often falls short against prions. Autoclaving at the temperatures used for ordinary surgical instruments can leave a surviving fraction of prion infectivity, and paradoxically, higher autoclaving temperatures do not always help. The small subpopulations of prions that survive one round of autoclaving are not eliminated by simply autoclaving again, and they take on distinct biological characteristics. Fixatives like ethanol or formalin make the problem worse by stabilizing the misfolded protein and making it even harder to destroy by heat.

The most reliable chemical approaches use strong sodium hydroxide (lye) or concentrated sodium hypochlorite (bleach). Sodium hydroxide converts the resistant form of the prion protein into a version that enzymes can digest, effectively stripping away its armor. This works both on prions in solution and on those stuck to metal surfaces. Combining a sodium hydroxide soak with autoclaving is considered extremely effective and is the gold standard recommended by most infection-control guidelines. For instruments that cannot tolerate such harsh treatment, the practical fallback is to use single-use disposable tools for high-risk neurosurgical procedures in suspected or confirmed prion cases.

Ozone treatment has been explored for wastewater contexts, where conventional cleaning is not feasible. At rendering plants, a large proportion of infectious prions partition into the scum layer that forms during gravity separation of wastewater, while a significant amount persists in the liquid fraction. Managing prion contamination at an industrial scale remains an evolving challenge with no single easy solution.

Detecting Prions Before Symptoms Appear

A major obstacle to prevention is that prion diseases cannot be definitively diagnosed in a living person or animal using a simple blood test. Historically, confirmation required examining brain tissue after death. That has begun to change with amplification-based assays, particularly a technique called RT-QuIC, which works by providing a supply of normal prion protein and watching whether a patient sample can trigger the chain-reaction misfolding process in a test tube. The method detects vanishingly small amounts of misfolded protein in cerebrospinal fluid, nasal brushings, and other accessible tissues. It has been applied across multiple prion diseases and provides highly specific results, making antemortem diagnosis realistic for the first time.

For wildlife surveillance, RT-QuIC is being used on rectal biopsies and lymphoid tissue from live deer, allowing wildlife agencies to test animals without killing them. The same principle underpins the detection of prion shedding in saliva, urine, and feces referenced earlier in studies of CWD excretion. If these assays become cheap and fast enough for field deployment, they could help identify infected herds before the disease spreads further, which would be a significant step forward for both animal health and any downstream human risk.